Solid Lipid Nanoparticles

Solid lipid nanoparticles (SLNs) are produced from physiologically biocompatible lipids. They have been proven to improve solubility, cellular uptake, and stability, reduce enzyme degradation, prolong the circulation time of various drugs. SLNs applied in oral, parenteral, transdermal, intranasal, ocular, pulmonary drug delivery different drugs, with enhanced safety, bioavailability, overall therapeutic effects. In this entry, authors summarize primary features SLNs, methods prepare recent applications delivery. Owing their advantages, potential systems management diseases will, soon, be available for clinical use.